Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

875.355
-3.434-0.39%
Number of Gainers:5
Number of Losers:10
Number of Flat:2
PE:- -
High:881.693
Open:876.263
Low:873.621
Close:878.789
Volume:11.29M
Turnover:92.86M
Market Cap:590.36B
Float Cap:489.43B

Loading ...

HK Stock Market Update | Innovative Drug Stocks Face Continued Pullback Amid Shifting Overseas Rate Expectations and Post-2026 Negotiation Uncertainty

Stock News
·
Sep 11

Hong Kong Stock Market Flash | TYK Medicines-B Surges Over 9% as Chairman's Share Buyback Reinforces Confidence and Novel EGFR-TKI Gains Landmark Approval

Stock News
·
Sep 11

Lazard Asset Management Boosts Stake in SINOPHARM with HK$15 Million Share Purchase

Stock News
·
Sep 10

Sino Biopharmaceutical Stock Slides 2.3% in Hong Kong

Dow Jones
·
Sep 10

CSPC Pharmaceutical Group Stock Slips 3.6% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 10

AH Share Premium Rankings: September 10 Market Close Update

Stock News
·
Sep 10

Global Equities Roundup: Market Talk

Dow Jones
·
Sep 10

Hong Kong Market Flash | CSPC Pharma Drops Over 4% as Lp(a) HORIZON Study Setback May Pressure Participants Including the Company

Stock News
·
Sep 10

CSPC Pharma's Clinical Data Presentations Could be Near-Term Share Catalysts

Dow Jones
·
Sep 10

Morning Selloff Hits Mobile Supply Chain Stocks as Apple's Launch Fails to Offset Cost Pressures

Stock News
·
Sep 10

Ascletis Pharma Surges on US Obesity Drug Trial Launch

Deep News
·
Sep 10

Pharmaceutical Firms Divest Assets to Bolster Core Operations

Deep News
·
Sep 09

Trump Unveils Midterm Strategy: Tax Cuts and "MAHA Movement" Take Center Stage, Targeting Pharma and Processed Food Sectors

Stock News
·
Sep 09

Fosun Pharma's New Oral Drug for Vitiligo Gets Green Light for Phase III Trials

Deep News
·
Sep 09

Genfleet-B Repurchases 75,000 Shares for HK$1.96 Million on September 9

Stock News
·
Sep 09

CSPC Pharma Gets Clinical Trial Nod in China for Solid Tumors Drug

MT Newswires Live
·
Sep 09

CSPC Pharmaceutical Says Rotigotine Long-Acting Injection Gets Clinical Trial Approval in China

Reuters
·
Sep 09

CSPC Pharma's Goserelin Extended-Release Injection Gets Clinical Trial Green Light in China

Stock News
·
Sep 09

CSPC Pharma Gains Chinese Clinical Trial Approval for Goserelin Extended-Release Injection

Stock News
·
Sep 09

CSPC Pharma Wins China Clinical Trial Clearance for Syh9102 Goserelin Injection

Reuters
·
Sep 09